Dan Ory
Tracked across 1 events · 7 articles · First seen Sep 08, 2026 · Last active Sep 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Editas Medicine, a U.S. gene editing company, announced on September 8, 2026, the appointment of Dan Ory, M.D., as Chief Medical Officer, effective immediately. Dr. Ory, a biotechnology executive with over 25 years of experience…
Impact: Dan Ory joined Editas Medicine as Chief Medical Officer, bringing extensive experience in cardiovascular and genetic medicine. His leadership is expected to strengthen Editas's clinical development capabilities.
Sep 08, 2026 · 7 articles
70
Editas Medicine appointed Dan OryEditas Medicine Appoints...
ERGEN INTELLIGENCE
Track Dan Ory live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard